StreetInsider.com News Articles

Oppenheimer on Tectonic Therapeutics Inc. (TECX): 'Reaction Provides Opportunity'

Tue, 01 Sep 2026 06:04:52 -0400

Oppenheimer analyst Leland Gershell reiterated an Outperform rating and $80.00 price target on Tectonic Therapeutics Inc. (NASDAQ: TECX).

The analyst comments "TECX shares are under pressure following AZN's LUMINARA Phase 2b readout at ESC—yet the data add support to our favorable outlook on TX45, and we would take advantage of the weakness. LUMINARA provides the first evidence of efficacy with chronic relaxin agonism in heart failure, alongside clear target engagement and reassuring safety. Following our discussion with management, we also think the dose response supports TECX's view that appropriate relaxin exposure is critical, and emphasize that the study was not designed

Stifel: 'we continue to think there's a credible case TECX/TX45 offers the best test of the relaxin hypothesis'

Mon, 31 Aug 2026 10:58:39 -0400

Stifel: 'we continue to think there's a credible case TECX/TX45 offers the best test of the relaxin hypothesis'.

The analyst comments "We thought the detailed AZD5462 data were nuanced--but interesting. We also touched base with management on implications where ultimately we do think there are some positive (albeit complicated/nuanced) takeaways for APEX/relaxin broadly. More notably--this is another encouraging datapoint re:safety. But also this is arguably the first signals of efficacy w/relaxin in a chronicHF setting where we see durable hemodynamic changes (no tachyphylaxis; and some signals on NTproBNP, LVEF). Now to be clear, the overall dataset is definitely messy and the

Form 144 Tectonic Therapeutic, Filed by: MCGUIRE TERRANCE

Thu, 27 Aug 2026 17:20:00 -0400

si-local-file:///var/storage/secattach/20260827/26991263.html

Form 144 Tectonic Therapeutic, Filed by: MCGUIRE TERRANCE

Thu, 27 Aug 2026 17:20:00 -0400

si-local-file:///var/storage/secattach/20260827/26991263.html

Form 4 Tectonic Therapeutic, For: Aug 25 Filed by: McNamara Peter

Wed, 26 Aug 2026 16:31:00 -0400

si-local-file:///var/storage/secattach/20260826/26982261.html

Form 4 Tectonic Therapeutic, For: Aug 25 Filed by: McNamara Peter

Wed, 26 Aug 2026 16:31:00 -0400

si-local-file:///var/storage/secattach/20260826/26982261.html

Form 144 Tectonic Therapeutic, Filed by: MCGUIRE TERRANCE

Fri, 21 Aug 2026 17:58:00 -0400

si-local-file:///var/storage/secattach/20260821/26962628.html

Form 144 Tectonic Therapeutic, Filed by: MCGUIRE TERRANCE

Fri, 21 Aug 2026 17:58:00 -0400

si-local-file:///var/storage/secattach/20260821/26962628.html

Form 4 Tectonic Therapeutic, For: Aug 12 Filed by: McNamara Peter

Fri, 14 Aug 2026 19:26:00 -0400

si-local-file:///var/storage/secattach/20260814/26933226.html

Form 4 Tectonic Therapeutic, For: Aug 12 Filed by: McNamara Peter

Fri, 14 Aug 2026 19:26:00 -0400

si-local-file:///var/storage/secattach/20260814/26933226.html

Form 144 Tectonic Therapeutic, Filed by: McNamara Peter

Wed, 12 Aug 2026 16:38:00 -0400

si-local-file:///var/storage/secattach/20260812/26913611.html

Form 144 Tectonic Therapeutic, Filed by: McNamara Peter

Wed, 12 Aug 2026 16:38:00 -0400

si-local-file:///var/storage/secattach/20260812/26913611.html

Tectonic Therapeutics Inc. (TECX) PT Lowered to $93 at Wells Fargo

Fri, 07 Aug 2026 08:20:38 -0400

Wells Fargo analyst Ben Burnett lowered the price target on Tectonic Therapeutics Inc. (NASDAQ: TECX) to $93.00 (from $101.00) while maintaining a Overweight rating.

Tectonic Therapeutic (TECX) Tops Q2 EPS by 17c

Thu, 06 Aug 2026 18:08:03 -0400

Tectonic Therapeutic (NASDAQ: TECX) reported Q2 EPS of ($1.18), $0.17 better than the analyst estimate of ($1.35).

For earnings history and earnings-related data on Tectonic Therapeutic (TECX) click here.

Form 10-Q Tectonic Therapeutic, For: Jun 30

Thu, 06 Aug 2026 16:17:00 -0400

si-local-file:///var/storage/secattach/20260806/26884289.html

Form 10-Q Tectonic Therapeutic, For: Jun 30

Thu, 06 Aug 2026 16:17:00 -0400

si-local-file:///var/storage/secattach/20260806/26884289.html

Form 8-K Tectonic Therapeutic, For: Aug 06

Thu, 06 Aug 2026 16:11:00 -0400

si-local-file:///var/storage/secattach/20260806/26883939.html

Form 8-K Tectonic Therapeutic, For: Aug 06

Thu, 06 Aug 2026 16:11:00 -0400

si-local-file:///var/storage/secattach/20260806/26883939.html

Tectonic Therapeutic Announces Second Quarter 2026 Financial Results and Recent Business Highlights

Thu, 06 Aug 2026 16:01:00 -0400

Enrollment completed in TX45 APEX Phase 2 clinical trial in patients with pulmonary hypertension associated with heart failure with preserved ejection fraction (“PH-HFpEF”) with topline results anticipated in early Q1 2027
TX45 APEX Phase 2 clinical trial Independent Data Monitoring Committee (“IDMC”) met in July 2026 and recommended continuation of the study without modification
TX2100, a potential treatment for Hereditary Hemorrhagic Telangiectasia (“HHT”), completed dosing of the six single dose healthy volunteer cohorts in the Phase 1a clinical trial, with topline results anticipated by end of Q3 2026
Cash and cash equivalents were $227.1 million as of June 30, 2026, including approximately $11.7

Tectonic Therapeutic Announces Second Quarter 2026 Financial Results and Recent Business Highlights

Thu, 06 Aug 2026 16:01:00 -0400

Enrollment completed in TX45 APEX Phase 2 clinical trial in patients with pulmonary hypertension associated with heart failure with preserved ejection fraction (“PH-HFpEF”) with topline results anticipated in early Q1 2027
TX45 APEX Phase 2 clinical trial Independent Data Monitoring Committee (“IDMC”) met in July 2026 and recommended continuation of the study without modification
TX2100, a potential treatment for Hereditary Hemorrhagic Telangiectasia (“HHT”), completed dosing of the six single dose healthy volunteer cohorts in the Phase 1a clinical trial, with topline results anticipated by end of Q3 2026
Cash and cash equivalents were $227.1 million as of June 30, 2026, including approximately $11.7

Form 4 Tectonic Therapeutic, For: Jun 30 Filed by: McNamara Peter

Wed, 01 Jul 2026 17:20:00 -0400

si-local-file:///var/storage/secattach/20260701/26722116.html

Form 4 Tectonic Therapeutic, For: Jun 30 Filed by: McNamara Peter

Wed, 01 Jul 2026 17:20:00 -0400

si-local-file:///var/storage/secattach/20260701/26722116.html

Form 144 Tectonic Therapeutic, Filed by: McNamara Peter

Tue, 30 Jun 2026 16:38:00 -0400

si-local-file:///var/storage/secattach/20260630/26714269.html

Form 144 Tectonic Therapeutic, Filed by: McNamara Peter

Tue, 30 Jun 2026 16:38:00 -0400

si-local-file:///var/storage/secattach/20260630/26714269.html

Form 4 Tectonic Therapeutic, For: Jun 20 Filed by: REICIN ALISE

Tue, 23 Jun 2026 17:52:00 -0400

si-local-file:///var/storage/secattach/20260623/26680792.html